WO2024058498A1 - Système ultrasonore focalisé non invasif de faible intensité pour stimulation cérébrale profonde - Google Patents
Système ultrasonore focalisé non invasif de faible intensité pour stimulation cérébrale profonde Download PDFInfo
- Publication number
- WO2024058498A1 WO2024058498A1 PCT/KR2023/013480 KR2023013480W WO2024058498A1 WO 2024058498 A1 WO2024058498 A1 WO 2024058498A1 KR 2023013480 W KR2023013480 W KR 2023013480W WO 2024058498 A1 WO2024058498 A1 WO 2024058498A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- low
- transducer
- intensity
- deep brain
- brain stimulation
- Prior art date
Links
- 238000002604 ultrasonography Methods 0.000 title claims abstract description 45
- 210000004556 brain Anatomy 0.000 title claims abstract description 31
- 230000000638 stimulation Effects 0.000 title claims abstract description 25
- 238000004088 simulation Methods 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims description 7
- 230000004936 stimulating effect Effects 0.000 claims description 4
- 230000001678 irradiating effect Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 description 12
- 238000011491 transcranial magnetic stimulation Methods 0.000 description 10
- 238000002595 magnetic resonance imaging Methods 0.000 description 8
- 208000024714 major depressive disease Diseases 0.000 description 8
- 208000020401 Depressive disease Diseases 0.000 description 7
- 238000012360 testing method Methods 0.000 description 6
- 206010054089 Depressive symptom Diseases 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 208000028017 Psychotic disease Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 210000002442 prefrontal cortex Anatomy 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 3
- 239000000935 antidepressant agent Substances 0.000 description 3
- 229940005513 antidepressants Drugs 0.000 description 3
- 238000002591 computed tomography Methods 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000000306 recurrent effect Effects 0.000 description 3
- 206010010144 Completed suicide Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000004326 gyrus cinguli Anatomy 0.000 description 2
- 210000001009 nucleus accumben Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 206010050013 Abulia Diseases 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 206010066392 Fear of death Diseases 0.000 description 1
- 206010016374 Feelings of worthlessness Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037211 Psychomotor hyperactivity Diseases 0.000 description 1
- 206010037213 Psychomotor retardation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010042458 Suicidal ideation Diseases 0.000 description 1
- 206010042464 Suicide attempt Diseases 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
Definitions
- the present invention relates to an ultrasound system, and more particularly, to a low-intensity non-invasive focused ultrasound system for deep brain stimulation.
- Ultrasound is a sound wave with a frequency greater than the audible frequency (16 Hz to 20 kHz), and is widely used in existing clinical trials by being applied to ultrasonic medical imaging devices, high-intensity focused ultrasound surgery devices, and ultrasound tumor treatment devices.
- DLPFC Dorsolateral Prefrontal Cortex
- CC Cingulate Cortex
- NAcc Nucleus Accumbens
- TMS transcranial magnetic stimulation
- TMS transcranial magnetic stimulation
- the present invention was devised to solve the above problems, and the problem to be solved by the present invention is to provide a low-intensity non-invasive focused type for deep brain stimulation that can alleviate symptoms by stimulating the deep brain of patients with depression. It provides an ultrasonic system.
- a pulse bundle 150 consisting of pulses 160 of a first frequency is generated by ultrasonic waves 120 with a low intensity of ISPPA (Intensity Spatial Peak Pulse Average) 50 W/cm 2 or less. and an ultrasonic generator 200 that forms and outputs a second frequency with a pulse bundle 150;
- a transducer (110) connected to the ultrasonic generator and irradiating ultrasonic waves by contacting the head (130);
- an image display means for displaying the simulation results based on the output signal of the transducer 110 by superimposing them on the MRI image 100 of the head 130.
- the transducer 110 can be operated while viewing the simulation results.
- a low-intensity non-invasive focused ultrasound device for deep brain stimulation is provided.
- the low intensity is ISPPA 14 W/cm 2 or less.
- the first frequency is 10 to 10,000 Hz
- the second frequency is 1.4 to 10 Hz.
- the ultrasonic waves are in the low frequency band of 240 to 260 kHz.
- the output signals of the transducer 110 are the current and voltage signals of the transducer 110.
- the transducer 110 forms a focus of 10 mm or less (preferably 3 to 7 mm) with 90% of the focused energy at a distance of 20 to 40 mm from the surface of the transducer 110.
- the ultrasonic generator 200 operates in the range of 60 seconds to 3,600 seconds.
- the object of the present invention as described above is another category, a method of stimulating the deep brain using the above-described ultrasonic device, wherein the ultrasonic generator 200 has a low intensity of ISPPA (Intensity Spatial Peak Pulse Average) 50 W/cm 2 or less. And generating a pulse bundle 150 consisting of pulses 160 of a first frequency using ultrasonic waves 120 in a low frequency band of 240 to 260 KHz, and forming and outputting a second frequency using the pulse bundle 150.
- ISPPA Intensity Spatial Peak Pulse Average
- the transducer 110 irradiates ultrasonic waves to the head 130, so that 90% of the focused energy forms a focus of 10 mm or less at a distance of 20 to 40 mm from the surface of the transducer 110;
- the symptoms of depression patients who have not seen any effect from transcranial magnetic stimulation can be alleviated by stimulating the deep brain area with ultrasound.
- TMS transcranial magnetic stimulation
- the focused ultrasound according to the present invention safely stimulates the left dorsolateral prefrontal cortex (DLPFC) area of the cerebrum, which can serve as a scientific basis for its use in the treatment of major depressive disorder.
- DLPFC dorsolateral prefrontal cortex
- Figure 1 is an example of simulation results for a low-intensity non-invasive focused ultrasound system and MRI images for deep brain stimulation according to the present invention
- Figure 2 is a waveform diagram of an ultrasonic system according to the present invention.
- first and second are used to distinguish one component from another component, and the scope of rights should not be limited by these terms.
- a first component may be named a second component, and similarly, the second component may also be named a first component.
- first component may be named a second component, and similarly, the second component may also be named a first component.
- second component When a component is referred to as being “connected” to another component, it should be understood that it may be directly connected to the other component, but that other components may also exist in between.
- a component when a component is referred to as being “directly connected” to another component, it should be understood that there are no other components in between.
- other expressions that describe the relationship between components such as "between” and “immediately between” or “neighboring” and “directly neighboring” should be interpreted similarly.
- Figure 1 is an example of simulation results for a low-intensity non-invasive focused ultrasound system and MRI images for deep brain stimulation according to the present invention.
- the ultrasonic generator 200 is connected to the transducer 110, and the transducer 110 radiates ultrasonic waves 120 to the head 130.
- the image may be an MRI (Magnetic Resonance Imaging) image (100) or a CT (Computed Tomography) image.
- a dedicated program (simulation program) on the computer simulates and displays the intensity of the ultrasonic waves 120 based on the voltage and current signals of the transducer 110.
- the ultrasound 120 irradiated into the brain is indicated by the ultrasound range of the transducer 110.
- the ultrasound 40 is displayed as a cone or rectangle, and the inside of the rectangle changes in gradation from red to blue depending on the intensity.
- the length and direction of the cone-shaped ultrasonic wave 120 indicate the limit and direction of the ultrasonic wave 120, the red color inside can be the place where the ultrasonic intensity is the strongest, and the blue color can be the place where the ultrasonic intensity is the lowest. Accordingly, the therapist (operator) can operate the transducer 110 while viewing the simulation results (feedback effect).
- the ultrasonic generator 200 generates focused ultrasonic waves.
- the ultrasonic generator 200 can change an electrical waveform into a mechanical waveform using a piezoelectric material, and when the piezoelectric material is operated in a degassed medium (e.g., degassed water), an ultrasonic pressure shock waveform of 20 kHz or more is generated. It can be converted to .
- This shock wave is generated from the piezoelectric material arranged in a hemispherical shape and is concentrated at a location corresponding to the radius of curvature (ROC) of the hemispherical circumference.
- a degassed medium e.g., degassed water
- the intensity of the ultrasound 120 uses a low intensity of 50 W/cm 2 or less, and according to the standards of the Food and Drug Administration (hereinafter referred to as the Food and Drug Administration), the ultrasound applies an effective intensity of less than 3 W/cm 2 and does not cause heat or cavity ( It can be used within the range where cavitation phenomenon does not occur.
- the ultrasound stimulation to be used is a pressure sound wave type, and is provided at a frequency in the low-frequency band of 240 to 260 kHz (preferably 250 kHz), rather than the high-frequency ultrasound used in existing diagnostic ultrasound machines, so it can penetrate the skull and reach deep areas of the brain.
- the focus can be positioned up to
- the size (focus area) affected by the ultrasonic waves 120 is deep from the surface of the transducer 110, at a distance of 20 to 40 mm (preferably 30 mm), and 90% of the focused energy is at a focus of 10 mm or less (preferably Preferably 3 to 7 mm, more preferably 5 to 6 mm). Since this focal area is a sphere or oval-shaped cone (shaped like a grain of rice), detailed functional control of a specific area is possible. Additionally, it can be used within a range that does not exceed the Mechanical Safety Index of 1.9. Additionally, the core area can be selected in the range of 40 to 70 mm depending on the disease.
- FIG. 2 is a waveform diagram of an ultrasonic system according to the present invention.
- a pulse 160 is formed using an ultrasonic waveform of 250 kHz.
- the frequency of pulse 160 is 10 to 10,000 Hz.
- the single tone width (TBD) of the pulse 160 is 0.1 to 100 ms, and the duty cycle can be adjusted in the range of 1 to 100%.
- the pulse bundle 150 is composed of regular pulses 160, and the frequency of the pulse bundle 150 is 1.4 to 10 Hz.
- the width (SD) of the pulse bundle (sonic processing, 150) is set to 10 to 3,000 ms.
- the period (SI) of the pulse bundle (sonic wave processing, 150) is set to 10 to 7,000 ms.
- the total ultrasonic time (T/T) can be appropriately selected within the range of 60 seconds to 3,600 seconds. If it is less than 60 seconds, the effect of stimulation is minimal, and if it exceeds 3,600 seconds, excessive stimulation may cause excitement or side effects.
- image data is generated by taking an MRI image 100 and a CT image of the human head 130.
- patients with major depressive disorder who exhibit mild or more major depressive episodes without psychotic features are selected.
- the DSM-5 major depressive disorder diagnostic criteria must meet at least 5 of the 9 items below and must include at least one of 1. and 2.
- [Table 1] is a table showing the change in suicide ideation scale score (SSI) after 4 weeks compared to the baseline (mlTT).
- the present invention relates to an ultrasound system, and more particularly, to a low-intensity non-invasive focused ultrasound system for deep brain stimulation.
- T/T Total ultrasonic treatment time (Treatment Time)
- PRP Pulse Repetition Period
- PRF Pulse Repetition Frequency.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- High Energy & Nuclear Physics (AREA)
- Surgical Instruments (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Abstract
La présente invention concerne un système ultrasonore et, plus particulièrement, un système ultrasonore focalisé non invasif de faible intensité destiné à une stimulation cérébrale profonde. À cet effet, est fourni un dispositif ultrasonore focalisé non invasif de faible intensité destiné à une stimulation cérébrale profonde, comprenant : un générateur d'ultrasons (200) de faible intensité ayant une intensité moyenne d'impulsion de crête spatiale (ISPPA) de 50 W/cm2 ou moins, qui génère, au moyen d'ondes ultrasonores (120), un faisceau d'impulsions (150) comprenant des impulsions (160) d'une première fréquence, forme des impulsions d'une seconde fréquence à partir du faisceau d'impulsions (150), et délivre celles-ci ; un transducteur (110), qui est connecté au générateur d'ultrasons et vient en contact avec une tête (130) pour émettre les ondes ultrasonores ; et un moyen d'affichage d'image destiné à afficher un résultat de simulation sur la base du signal de sortie provenant du transducteur (110) par superposition de celui-ci sur une image IRM (100) de la tête (130), et ainsi la présente invention permet de faire fonctionner le transducteur (110) tout en visualisant le résultat de la simulation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220115788A KR102549663B1 (ko) | 2022-09-14 | 2022-09-14 | 뇌 심부 자극을 위한 저강도 비침습 집속형 초음파 시스템 |
KR10-2022-0115788 | 2022-09-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024058498A1 true WO2024058498A1 (fr) | 2024-03-21 |
Family
ID=86959534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2023/013480 WO2024058498A1 (fr) | 2022-09-14 | 2023-09-08 | Système ultrasonore focalisé non invasif de faible intensité pour stimulation cérébrale profonde |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR102549663B1 (fr) |
WO (1) | WO2024058498A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102549663B1 (ko) * | 2022-09-14 | 2023-06-30 | 주식회사 뉴로소나 | 뇌 심부 자극을 위한 저강도 비침습 집속형 초음파 시스템 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190047251A (ko) * | 2017-10-27 | 2019-05-08 | (주)헬스허브 | 초음파 안내하의 뇌 치료용 플랫폼 |
KR20190097165A (ko) * | 2016-12-22 | 2019-08-20 | 서니브룩 리서치 인스티튜트 | 경두개 초음파 치료 및 영상화 절차 수행을 위한 시스템 및 방법 |
KR20210033926A (ko) * | 2019-09-19 | 2021-03-29 | 기초과학연구원 | 세타-버스트 초음파를 이용한 신경 가소성 조절 장치 및 조절방법 |
KR20220009927A (ko) * | 2020-07-16 | 2022-01-25 | 주식회사 딥슨바이오 | 초음파를 조사하여 동적 압력에 의한 부피유동을 유도함으로써, 뇌 림프계의 노폐물 배출 촉진을 위한 초음파장치 |
US20220062661A1 (en) * | 2009-11-04 | 2022-03-03 | Arizona Board Of Regents On Behalf Of Arizona State University | Devices and methods for modulating brain activity |
KR102549663B1 (ko) * | 2022-09-14 | 2023-06-30 | 주식회사 뉴로소나 | 뇌 심부 자극을 위한 저강도 비침습 집속형 초음파 시스템 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100784117B1 (ko) | 2006-01-25 | 2007-12-12 | 주식회사 에스앤지바이오텍 | 두개골 매입형 초음파 24시간 뇌감시장치 |
KR101428547B1 (ko) | 2013-05-13 | 2014-08-11 | 주식회사 웨이전스 | 우울증 치료, 스트레스 해소 및 집중력 향상을 위한 헤드 셋 |
-
2022
- 2022-09-14 KR KR1020220115788A patent/KR102549663B1/ko active IP Right Grant
-
2023
- 2023-09-08 WO PCT/KR2023/013480 patent/WO2024058498A1/fr unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220062661A1 (en) * | 2009-11-04 | 2022-03-03 | Arizona Board Of Regents On Behalf Of Arizona State University | Devices and methods for modulating brain activity |
KR20190097165A (ko) * | 2016-12-22 | 2019-08-20 | 서니브룩 리서치 인스티튜트 | 경두개 초음파 치료 및 영상화 절차 수행을 위한 시스템 및 방법 |
KR20190047251A (ko) * | 2017-10-27 | 2019-05-08 | (주)헬스허브 | 초음파 안내하의 뇌 치료용 플랫폼 |
KR20210033926A (ko) * | 2019-09-19 | 2021-03-29 | 기초과학연구원 | 세타-버스트 초음파를 이용한 신경 가소성 조절 장치 및 조절방법 |
KR20220009927A (ko) * | 2020-07-16 | 2022-01-25 | 주식회사 딥슨바이오 | 초음파를 조사하여 동적 압력에 의한 부피유동을 유도함으로써, 뇌 림프계의 노폐물 배출 촉진을 위한 초음파장치 |
KR102549663B1 (ko) * | 2022-09-14 | 2023-06-30 | 주식회사 뉴로소나 | 뇌 심부 자극을 위한 저강도 비침습 집속형 초음파 시스템 |
Also Published As
Publication number | Publication date |
---|---|
KR102549663B1 (ko) | 2023-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Legon et al. | Neuromodulation with single‐element transcranial focused ultrasound in human thalamus | |
Downs et al. | Non-invasive peripheral nerve stimulation via focused ultrasound in vivo | |
US9089683B2 (en) | Neuromodulation method via deep-brain stimulation | |
Graziano et al. | Visuospatial properties of ventral premotor cortex | |
Bimbard et al. | Multi-scale mapping along the auditory hierarchy using high-resolution functional UltraSound in the awake ferret | |
WO2024058498A1 (fr) | Système ultrasonore focalisé non invasif de faible intensité pour stimulation cérébrale profonde | |
Ohara et al. | Cutaneous painful laser stimuli evoke responses recorded directly from primary somatosensory cortex in awake humans | |
Zhang et al. | Transcranial focused ultrasound neuromodulation: A review of the excitatory and inhibitory effects on brain activity in human and animals | |
US20040143300A1 (en) | Electromagnetic brain animation | |
WO2017107230A1 (fr) | Procédé de stimulation ou de régulation et de commande cérébrale ultrasonore et appareil fondé sur un élément de réseau de zones à grande échelle | |
CN107185113A (zh) | 治疗装置及包括该治疗装置的治疗设备 | |
Arulpragasam et al. | Low intensity focused ultrasound for non-invasive and reversible deep brain neuromodulation—a paradigm shift in psychiatric research | |
Boonzaier et al. | Design and evaluation of a rodent-specific transcranial magnetic stimulation coil: an in silico and in vivo validation study | |
Ilham et al. | In vitro single-unit recordings reveal increased peripheral nerve conduction velocity by focused pulsed ultrasound | |
Schimek et al. | Repeated application of transcranial diagnostic ultrasound towards the visual cortex induced illusory visual percepts in healthy participants | |
Hellstrand et al. | MEG localization of interictal epileptic focal activity and concomitant stereotactic radiosurgery. A non-invasive approach for patients with focal epilepsy | |
Park et al. | Application of subject-specific helmets for the study of human visuomotor behavior using transcranial focused ultrasound: a pilot study | |
Jürgens | Localization of a pontine vocalization-controlling area | |
Kawai et al. | Origins and conducting pathways of motor evoked potentials elicited by transcranial magnetic stimulation in cats | |
RU2621547C2 (ru) | Способ дистанционной мультиволновой электромагнитной радионейроинженерии головного мозга человека | |
Lebet et al. | Electroencephalographic changes following low energy emission therapy | |
Zhang et al. | Low-intensity transcranial ultrasound stimulation facilitates hand motor function and cortical excitability: A crossover, randomized, double blind study | |
Chae et al. | fMRI review on brain responses to acupuncture: the limitations and possibilities in traditional Korean acupuncture | |
Bao et al. | Personalized depth‐specific neuromodulation of the human primary motor cortex via ultrasound | |
Valiulis et al. | The use of MR‑less MNI based neuronavigation for 10 Hz rTMS depression therapy: electrophysiological and clinical implications\\r\\n |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23865796 Country of ref document: EP Kind code of ref document: A1 |